What is the typical probability of success for a drug in Phase 1 trials ?

Question

BlackTom AI · Accepted Answer

Phase 1 trials primarily assess safety and tolerability in humans, so a majority of investigational drugs that enter Phase 1 advance to Phase 2; historical industry data show this transition probability is about 63.2%.

1. Relevant knowledge points and concepts
- Clinical development proceeds in phases: Phase 1 (safety/tolerability), Phase 2 (proof-of-concept/efficacy), Phase 3 (confirmatory efficacy/safety).
- “Probability of success” for a phase commonly refers to the empirical chance a compound advances from that phase to the next (Phase 1 → Phase 2).
- Empirical industry transition rates are derived from large historical datasets of clinical programs.

2. Step-by-step reasoning
- Because Phase 1 focuses on safety in a small number of healthy volunteers or patients, fewer candidates are eliminated at this stage than later phases focused on efficacy.
- Historical aggregate analyses report that roughly 63.2% of candidates entering Phase 1 progress to Phase 2.

3. Calculations / intermediate steps
- If 100 investigational drugs enter Phase 1, expected number progressing ≈ 100 × 0.632 = 63.2 drugs.
- By contrast, using the other option values:
  - 100 × 0.307 = 30.7 (too few to match observed Phase 1 transition frequency)
  - 100 × 0.853 = 85.3 (implausibly high given typical safety/PK failures)
  - 100 × 0.505 = 50.5 (underestimates observed Phase 1 progression)

4. Why the correct answer is correct
- The 63.2% figure aligns with published, aggregated industry metrics for Phase 1 → Phase 2 transition probability and reflects that safety filters eliminate fewer candidates than efficacy-focused phases.

5. Why the other options are incorrect
- 30.7% is much lower than historical Phase 1 transition rates and more consistent with later-phase attrition or overall approval probabilities.
- 85.3% is unrealistically high; Phase 1 still has nontrivial safety/PK failures.
- 50.5% underestimates the empirically observed Phase 1 pass rate.

6. Conclusion
- The correct choice is 63.2%, which matches the provided answer.

What is the typical probability of success for a drug in Phase 1 trials ?单项选择题

类似问题

Multiple Choice: In which of the following cases would a randomized controlled trial be required to show efficacy of a probiotic supplement?

Which phase of clinical trials primarily aims to evaluate the efficacy and optimal dose of a new treatment in patients with the target disease?

Why is Australia an attractive location for conducting Phase I clinical trials?

Which member of the clinical trial team is responsible for the overall conduct of the trial at a study site?

How long do Phase III clinical trials typically run?

Which clinical trial design involves assigning participants to different treatment groups, where each group receives only one treatment throughout the study?

Adverse events are difficulties that participants reported about the interventions provided in the study. These are listed in the Results section. Based on what was reported in final paragraph of the results section, select from the list below which adverse event were reported by participants.

更多留学生实用工具

智能学习助手

风格化写作助手

论文查重助手

文献引用助手

课堂转译助手

课堂笔记助手

Quiz搜索助手

学校历年真题

智能刷题助手

智能匹配练习

希望你的学习变得更简单